Caseware UK (AP4) 2024.0.164 2024.0.164 2024-04-302024-04-30132023-05-01falseNo description of principal activity12falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 11928940 2023-05-01 2024-04-30 11928940 2022-05-01 2023-04-30 11928940 2024-04-30 11928940 2023-04-30 11928940 c:Director1 2023-05-01 2024-04-30 11928940 d:Buildings d:ShortLeaseholdAssets 2023-05-01 2024-04-30 11928940 d:Buildings d:ShortLeaseholdAssets 2024-04-30 11928940 d:Buildings d:ShortLeaseholdAssets 2023-04-30 11928940 d:OfficeEquipment 2023-05-01 2024-04-30 11928940 d:OfficeEquipment 2024-04-30 11928940 d:OfficeEquipment 2023-04-30 11928940 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 11928940 d:ComputerEquipment 2023-05-01 2024-04-30 11928940 d:ComputerEquipment 2024-04-30 11928940 d:ComputerEquipment 2023-04-30 11928940 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 11928940 d:OtherPropertyPlantEquipment 2023-05-01 2024-04-30 11928940 d:OtherPropertyPlantEquipment 2024-04-30 11928940 d:OtherPropertyPlantEquipment 2023-04-30 11928940 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 11928940 d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 11928940 d:Goodwill 2023-05-01 2024-04-30 11928940 d:Goodwill 2024-04-30 11928940 d:Goodwill 2023-04-30 11928940 d:CurrentFinancialInstruments 2024-04-30 11928940 d:CurrentFinancialInstruments 2023-04-30 11928940 d:CurrentFinancialInstruments d:WithinOneYear 2024-04-30 11928940 d:CurrentFinancialInstruments d:WithinOneYear 2023-04-30 11928940 d:ShareCapital 2024-04-30 11928940 d:ShareCapital 2023-04-30 11928940 d:SharePremium 2024-04-30 11928940 d:SharePremium 2023-04-30 11928940 d:OtherMiscellaneousReserve 2024-04-30 11928940 d:OtherMiscellaneousReserve 2023-04-30 11928940 d:RetainedEarningsAccumulatedLosses 2024-04-30 11928940 d:RetainedEarningsAccumulatedLosses 2023-04-30 11928940 c:OrdinaryShareClass1 2023-05-01 2024-04-30 11928940 c:OrdinaryShareClass1 2024-04-30 11928940 c:OrdinaryShareClass1 2023-04-30 11928940 c:FRS102 2023-05-01 2024-04-30 11928940 c:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 11928940 c:FullAccounts 2023-05-01 2024-04-30 11928940 c:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 11928940 d:WithinOneYear 2024-04-30 11928940 d:WithinOneYear 2023-04-30 11928940 d:BetweenOneFiveYears 2024-04-30 11928940 d:BetweenOneFiveYears 2023-04-30 11928940 d:Goodwill d:ExternallyAcquiredIntangibleAssets 2023-05-01 2024-04-30 11928940 2 2023-05-01 2024-04-30 11928940 d:Goodwill d:OwnedIntangibleAssets 2023-05-01 2024-04-30 11928940 e:PoundSterling 2023-05-01 2024-04-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 11928940









HEALTH AND LONGEVITY OPTIMISATION LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 APRIL 2024

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
 
 
  
REPORT TO THE DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF HEALTH AND LONGEVITY OPTIMISATION LIMITED
FOR THE YEAR ENDED 30 APRIL 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Health and Longevity Optimisation Limited for the year ended 30 April 2024 which comprise  the Statement of Financial Position and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants of Scotlandwe are subject to its ethical and other professional requirements which are detailed at https://icas.com/icas -framework-preparation -of-accounts.

This report is made solely to the Board of Directors of Health and Longevity Optimisation Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Health and Longevity Optimisation Limited and state those matters that we have agreed to state to the Board of Directors of Health and Longevity Optimisation Limited, as a body, in this report in accordance with the requirements of the Institute of Chartered Accountants of Scotland as detailed at https://icas.com/icas -framework-preparation -of-accounts. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Health and Longevity Optimisation Limited and its Board of Directors, as a body, for our work or for this report. 

It is your duty to ensure that Health and Longevity Optimisation Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Health and Longevity Optimisation Limited. You consider that Health and Longevity Optimisation Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Health and Longevity Optimisation Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



Wilson Partners Limited
Chartered Accountants
 
Windsor House
Station Court
Station Road
Great Shelford
Cambridge
CB22 5NE
24 February 2025
Page 1

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
REGISTERED NUMBER: 11928940

STATEMENT OF FINANCIAL POSITION
AS AT 30 APRIL 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 5 
28,739
-

Tangible assets
 6 
1,380,997
1,676,623

  
1,409,736
1,676,623

Current assets
  

Debtors: amounts falling due within one year
 7 
488,906
453,671

Cash at bank and in hand
 8 
89,852
312,369

  
578,758
766,040

Creditors: amounts falling due within one year
 9 
(12,407,233)
(9,784,580)

Net current liabilities
  
 
 
(11,828,475)
 
 
(9,018,540)

Total assets less current liabilities
  
(10,418,739)
(7,341,917)

  

Net liabilities
  
(10,418,739)
(7,341,917)


Capital and reserves
  

Called up share capital 
  
1
1

Share premium account
  
1,929
1,359

Other reserves
  
(7,343,280)
(4,029,362)

Profit and loss account
  
(3,077,389)
(3,313,915)

  
(10,418,739)
(7,341,917)


Page 2

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
REGISTERED NUMBER: 11928940
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 APRIL 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Natalia Mikheev
Director

Date: 24 February 2025

The notes on pages 4 to 10 form part of these financial statements.

Page 3

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1.


General information

The company is registered in England and Wales and its registration number is 11928940. It is a private limited company limited by shares.
Registered Office:
Hooke
86 Brook Street
London
England
W1K 5AY

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Comprehensive Income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 4

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

2.Accounting policies (continued)

 
2.3

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.


 
2.7

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the Statement of Comprehensive Income over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Page 5

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

2.Accounting policies (continued)

 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.



The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the year end and the amounts reported for turnover and expenses during the year.
The director does not consider there to be any critical judgements or key sources of estimation uncertainty involved in the preparation of the company's financial statements. 

Page 6

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

4.


Employees

The average monthly number of employees, including directors, during the year was 12 (2023 - 13).


5.


Intangible assets




Goodwill

£



Cost


Additions
35,676



At 30 April 2024

35,676



Amortisation


Charge for the year on owned assets
6,937



At 30 April 2024

6,937



Net book value



At 30 April 2024
28,739



At 30 April 2023
-



Page 7

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

6.


Tangible fixed assets





Leasehold improvements
Office equipment
Computer equipment
Other fixed assets
Total

£
£
£
£
£



Cost or valuation


At 1 May 2023
1,960,553
59,516
154,579
-
2,174,648


Additions
8,060
15,015
-
67,382
90,457


Disposals
-
-
(1,995)
-
(1,995)



At 30 April 2024

1,968,613
74,531
152,584
67,382
2,263,110



Depreciation


At 1 May 2023
374,983
33,582
89,460
-
498,025


Charge for the year on owned assets
316,895
17,440
36,854
12,899
384,088



At 30 April 2024

691,878
51,022
126,314
12,899
882,113



Net book value



At 30 April 2024
1,276,735
23,509
26,270
54,483
1,380,997



At 30 April 2023
1,585,570
25,934
65,119
-
1,676,623


7.


Debtors

2024
2023
£
£


Trade debtors
28,933
2,844

Other debtors
302,376
326,288

Prepayments and accrued income
157,597
124,539

488,906
453,671


Page 8

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

8.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
89,852
312,369

89,852
312,369



9.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
138,086
82,034

Amounts owed to group undertakings
12,017,203
9,557,202

Other taxation and social security
2,240
35,347

Accruals and deferred income
249,704
109,997

12,407,233
9,784,580



10.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



8,500 (2023 - 8,300) Ordinary shares of £0.000125 each
1
1



11.


Commitments under operating leases

At 30 April 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Not later than 1 year
330,946
330,946

Later than 1 year and not later than 5 years
330,946
661,892

661,892
992,838

Page 9

 
HEALTH AND LONGEVITY OPTIMISATION LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

12.


Related party transactions

Included in creditors there is an amount owed to a related party of £11,921,480 (2023: £9,461,479). This amouint is interest free and repayable on demand.


13.


Controlling party

The ultimate controlling party is White Owl Investments Ltd by virtue of their shareholding.

 
Page 10